SEP 7, 2026 · JOURNAL ARTICLE
Clinical translation of CLDN18.2 and FGFR2b targeting in gastric cancer through assay thresholds and combination strategies
Discover Oncology
A narrative review synthesizing evidence across randomized trials and translational studies to distinguish established clinical practice from exploratory strategies in gastric cancer biomarker-directed therapy.
Study details
DesignNarrative review
InterventionCLDN18.2-directed therapy (zolbetuximab plu…